PATENT CLAIM ANALYSIS

Application Number: 16104045
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "020900"]

Abstract:
The invention features compounds of formula I or II: In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.

Claim (Index 3):
The oligonucleotide of  claim 1 , wherein the ligand is selected from the group consisting of thyrotropin, melanotropin, lectin, glycoprotein, surfactant protein A, Mucin carbohydrate, multivalent lactose, multivalent galactose, N-acetyl-galactosamine, multivalent N-acetyl-galactosamine, N-acetyl-glucosamine, multivalent N-acetyl glucosamine, multivalent mannose, multivalent fucose, glycosylated polyaminoacids, mannose, lactose, galactose, transferrin, bisphosphonate, polyglutamate, polyaspartate, a lipid, cholesterol, a steroid, bile acid, folate, vitamin B12, biotin, and an RGD peptide.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.46341
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13120389', '14918022', '13575461', '15395221', '12328537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8613482811604205
- 35 USC 102 Novelty (BERT): 0.5917051795706011
- Combined Prediction Score: 0.8343839710014386
- Mean Citation Score: 502.440568
- Max Citation Score: 653.3163
- Similarity Product: 412.6676113611102

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test